Ross Allison C, Judd Suzanne, Kumari Meena, Hileman Corrilynn, Storer Norma, Labbato Danielle, Tangpricha Vin, McComsey Grace A
Emory University School of Medicine, Atlanta, GA, USA.
Antivir Ther. 2011;16(4):555-63. doi: 10.3851/IMP1784.
Patients with HIV infection are at increased risk of cardiovascular disease (CVD). Vitamin D insufficiency has been associated with increased CVD risk in non-HIV populations. This study sought to determine the relationship between vitamin D status and markers of CVD and HIV-related factors in HIV-positive patients.
Patients with HIV infection on antiretroviral therapy and healthy controls were prospectively enrolled. Fasting lipids, glucose, insulin, inflammatory markers (soluble tumour necrosis factor-α receptor I, interleukin-6 and high-sensitivity C-reactive protein) and endothelial markers (soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1) were measured. Fasting 25-hydroxyvitamin D (25(OH)D) was measured from stored serum samples. The internal carotid artery and common carotid artery (CCA) intima-media thickness (IMT) were measured in a subset of HIV-positive patients. Baseline cross-sectional data were analysed.
A total of 149 HIV-positive patients (56 with carotid IMT) and 34 controls were included. Controls had higher adjusted mean 25(OH)D levels than HIV-positive patients (P=0.02). In multivariable linear regression among the HIV-positive patients, 25(OH)D was positively associated with CD4(+) T-cell restoration after antiretroviral therapy (ΔCD4 = current - nadir CD4(+) T-cell; P<0.01), but was not associated with inflammatory or endothelial markers. In multivariable logistic regression, odds of having CCA IMT above the median were more than 10× higher in those with lower 25(OH)D levels (OR=10.62, 95% CI 1.37-82.34; P<0.01).
Vitamin D status in HIV-positive patients was positively associated with improved immune restoration after antiretroviral therapy and negatively associated with CCA IMT. These findings suggest that vitamin D may play a role in HIV-related CVD and in immune reconstitution after antiretroviral therapy.
HIV感染患者患心血管疾病(CVD)的风险增加。维生素D不足与非HIV人群中CVD风险增加有关。本研究旨在确定HIV阳性患者中维生素D状态与CVD标志物及HIV相关因素之间的关系。
前瞻性纳入接受抗逆转录病毒治疗的HIV感染患者和健康对照。测量空腹血脂、血糖、胰岛素、炎症标志物(可溶性肿瘤坏死因子-α受体I、白细胞介素-6和高敏C反应蛋白)和内皮标志物(可溶性细胞间黏附分子-1和可溶性血管细胞黏附分子-1)。从储存的血清样本中测量空腹25-羟维生素D(25(OH)D)。在一部分HIV阳性患者中测量颈内动脉和颈总动脉(CCA)内膜中层厚度(IMT)。分析基线横断面数据。
共纳入149例HIV阳性患者(56例有颈动脉IMT)和34例对照。对照的校正后平均25(OH)D水平高于HIV阳性患者(P = 0.02)。在HIV阳性患者的多变量线性回归中,25(OH)D与抗逆转录病毒治疗后CD4(+)T细胞恢复呈正相关(ΔCD4 = 当前 - 最低CD4(+)T细胞;P < 0.01),但与炎症或内皮标志物无关。在多变量逻辑回归中,25(OH)D水平较低者CCA IMT高于中位数的几率高出10倍以上(OR = 10.62,95%CI 1.37 - 82.34;P < 0.01)。
HIV阳性患者的维生素D状态与抗逆转录病毒治疗后免疫恢复改善呈正相关,与CCA IMT呈负相关。这些发现表明维生素D可能在HIV相关CVD及抗逆转录病毒治疗后的免疫重建中起作用。